Strokes are a blood clot or bleed in the brain which can cause lasting damage, affecting mobility, thinking, sight or communication. Stroke has a major impact on individual lives and on the nation's health and economy.

Stroke is the UK's third biggest killer. Many people who live after having a stroke are left with paralysis, speech and mobility difficulties. The aftermath of stroke can lead to many negative social consequences such as loss of income, home and relationship break up.  The Stroke Assocation Reports that 11% of patients who have had stroke are admitted to residential care on discharge from hospital.

Stroke, like other vascular diseases such as heart disease, is often preventable. Atrial Fibrillation (AF) is a major cause of stroke. AF causes a fast and erratic heartbeat. It is common, mainly occurring in older people and increases with age. Many people with AF have no symptoms, particularly if their heart rate is not very fast. Current testing for AF involves the use of electro- cardiogram (ECG), sometimes required to be undertaken over a 24 hour period; some AF can be detected by taking a persons pulse. Once detected, AF can be treated with very good results and the risk of having a stroke greatly reduced. Identification and management of atrial fibrillation in the general population is key theme in the preventative element of the stroke strategy. The prescribing and monitoring of Warfarin is highly effective in the prevention of stroke, reducing the risk by up to 64%.

Scope

The desired outcomes of the proposed technology development must cover the following areas:-

• Identifying people with AF in the general population
• Enabling remote monitoring and treatment of AF
• Supporting rehabilitation and recovery for people following stroke
• Have sufficient flexibility to be used in general community settings
• Provide information and or intervention which may lead to a reduction in strokes